# Unraveling the Link Between Mitochondrial Dynamics and Neuroinflammation

**Authors:** Lilian Gomes de Oliveira, Yan de Souza Angelo, Antonio H. Iglesias, Jean Pierre Schatzmann Peron

PMC · DOI: 10.3389/fimmu.2021.624919 · Frontiers in Immunology · 2021-03-16

## TL;DR

This paper explores how mitochondrial dynamics influence neuroinflammation and their role in neurodegenerative diseases like Parkinson's and Alzheimer's.

## Contribution

The paper highlights novel connections between mitochondrial dysfunction and immune responses in central nervous system diseases.

## Key findings

- Mitochondrial Ca2+ homeostasis alterations induce innate immune pathways linked to neuroinflammation.
- Regulating mitochondrial dynamics reduces oxidative stress and promotes cell viability in CNS diseases.
- Mitochondrial DNA and mtROS contribute to type I IFN responses and neurodegeneration.

## Abstract

Neuroinflammatory and neurodegenerative diseases are a major public health problem worldwide, especially with the increase of life-expectancy observed during the last decades. For many of these diseases, we still lack a full understanding of their etiology and pathophysiology. Nonetheless their association with mitochondrial dysfunction highlights this organelle as an important player during CNS homeostasis and disease. Markers of Parkinson (PD) and Alzheimer (AD) diseases are able to induce innate immune pathways induced by alterations in mitochondrial Ca2+ homeostasis leading to neuroinflammation. Additionally, exacerbated type I IFN responses triggered by mitochondrial DNA (mtDNA), failures in mitophagy, ER-mitochondria communication and mtROS production promote neurodegeneration. On the other hand, regulation of mitochondrial dynamics is essential for CNS health maintenance and leading to the induction of IL-10 and reduction of TNF-α secretion, increased cell viability and diminished cell injury in addition to reduced oxidative stress. Thus, although previously solely seen as power suppliers to organelles and molecular processes, it is now well established that mitochondria have many other important roles, including during immune responses. Here, we discuss the importance of these mitochondrial dynamics during neuroinflammation, and how they correlate either with the amelioration or worsening of CNS disease.

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Tafazzin (tafazzin, phospholipid-lysophospholipid transacylase) [NCBI Gene 66826] {aka 5031411C02Rik, 9130012G04Rik, G4.5, Taz}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, IFNAR2 (interferon alpha and beta receptor subunit 2) [NCBI Gene 3455] {aka IFN-R, IFN-R-2, IFN-alpha-REC, IFNABR, IFNARB, IMD45}, Dnm1l (dynamin 1-like) [NCBI Gene 74006] {aka 6330417M19Rik, Dlp1, Dnmlp1, Drp1, python}, Map1lc3a (microtubule-associated protein 1 light chain 3 alpha) [NCBI Gene 66734] {aka 1010001H21Rik, 4922501H04Rik, LC3, LC3a}, Tbk1 (TANK-binding kinase 1) [NCBI Gene 56480] {aka 1200008B05Rik}, SSRP1 (structure specific recognition protein 1) [NCBI Gene 6749] {aka FACT, FACT80, T160}, Rhot1 (ras homolog family member T1) [NCBI Gene 59040] {aka 2210403N23Rik, Arht1, C430039G08Rik, Miro1}, Mavs (mitochondrial antiviral signaling protein) [NCBI Gene 228607] {aka D430028G21Rik, IPS-1, Visa, cardif}, Gsk3b (glycogen synthase kinase 3 beta) [NCBI Gene 56637] {aka 7330414F15Rik, 8430431H08Rik, GSK-3, GSK-3beta, GSK3}, Bak1 (BCL2-antagonist/killer 1) [NCBI Gene 12018] {aka Bak, N-BAK1, N-Bak}, Bax (BCL2-associated X protein) [NCBI Gene 12028], Irf3 (interferon regulatory factor 3) [NCBI Gene 54131] {aka C920001K05Rik, IRF-3}, Rigi (RNA sensor RIG-I) [NCBI Gene 230073] {aka 6430573D20Rik, C330021E21, Ddx58, RIG-I, RLR-1}, IFNAR1 (interferon alpha and beta receptor subunit 1) [NCBI Gene 3454] {aka AVP, CRF2-1, IFN-R-1, IFN-alpha-REC, IFNAR, IFNBR}, IFNA8 (interferon alpha 8) [NCBI Gene 3445] {aka IFN-alphaB}, Mfn2 (mitofusin 2) [NCBI Gene 170731] {aka D630023P19Rik, Fzo}, TLR9 (toll like receptor 9) [NCBI Gene 54106] {aka CD289}, STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061] {aka ERIS, MITA, MPYS, NET23, SAVI, STING}, Ikbkg (inhibitor of kappaB kinase gamma) [NCBI Gene 16151] {aka 1110037D23Rik, IKK[g], NEMO}, Nfatc2 (nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 2) [NCBI Gene 18019] {aka NF-ATc2, NF-ATp, NFAT1, NFAT1-D, Nfatp}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, Tlr2 (toll-like receptor 2) [NCBI Gene 24088] {aka Ly105}, Mfn1 (mitofusin 1) [NCBI Gene 67414] {aka 2310002F04Rik, 6330416C07Rik, D3Ertd265e, HR2, mKIAA4032}, Opa1 (OPA1, mitochondrial dynamin like GTPase) [NCBI Gene 74143] {aka 1200011N24Rik, lilr3, mKIAA0567}, Il18 (interleukin 18) [NCBI Gene 16173] {aka Igif, Il-18}, Fus (fused in sarcoma) [NCBI Gene 233908] {aka D430004D17Rik, D930039C12Rik, Fus1, Tls}, Tnfaip3 (tumor necrosis factor, alpha-induced protein 3) [NCBI Gene 21929] {aka A20, Tnfip3}, Hk2 (hexokinase 2) [NCBI Gene 15277] {aka HKII}, Park7 (Parkinson disease (autosomal recessive, early onset) 7) [NCBI Gene 57320] {aka DJ-1, Dj1}, Gsdma (gasdermin A) [NCBI Gene 57911] {aka Gsdm, Gsdm1, Gsdma1, H312E}, Il1 (interleukin 1 complex) [NCBI Gene 111343] {aka Il-1}, Dnm2 (dynamin 2) [NCBI Gene 13430] {aka Dyn2, Udnm, b2b2159Clo}, DIABLO (diablo IAP-binding mitochondrial protein) [NCBI Gene 56616] {aka DFNA64, SMAC}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Rmdn3 (regulator of microtubule dynamics 3) [NCBI Gene 67809] {aka 1200015F23Rik, Fam82a2, Ptpip51, RMD-3, Rmd3}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, Ticam2 (TIR domain containing adaptor molecule 2) [NCBI Gene 225471] {aka B430113A10, TICAM-2, TRAM, Tirp, Trif}, Lepr (leptin receptor) [NCBI Gene 24536] {aka Fa}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Cgas (cyclic GMP-AMP synthase) [NCBI Gene 214763] {aka E330016A19Rik, Mb21d1}, Casp1 (caspase 1) [NCBI Gene 12362] {aka ICE, Il1bc}, Aim2 (absent in melanoma 2) [NCBI Gene 383619] {aka Gm1313, Ifi210}, Hspa9 (heat shock protein family A (Hsp70) member 9) [NCBI Gene 15526] {aka 74kDa, Csa, Grp75, Hsc74, Hsp74, Hsp74a}, Fis1 (fission, mitochondrial 1) [NCBI Gene 66437] {aka 2010003O14Rik, Ttc11}, Ifih1 (interferon induced with helicase C domain 1) [NCBI Gene 71586] {aka 9130009C22Rik, Helicard, Hlcd, MDA5, RLR-2}, Nod2 (nucleotide-binding oligomerization domain containing 2) [NCBI Gene 257632] {aka ACUG, BLAU, CD, Card15, F830032C23Rik, IBD1}, Gbp2 (guanylate binding protein 2) [NCBI Gene 14469], Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Ager (advanced glycosylation end product-specific receptor) [NCBI Gene 11596] {aka RAGE}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 287362] {aka Cias1}, Vapb (vesicle-associated membrane protein, associated protein B and C) [NCBI Gene 56491] {aka D2Abb2e, VAMP-B, VAP-B, VAP33b, Vamp33b}, Sting1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 72512] {aka 2610307O08Rik, ERIS, MPYS, Mita, STING, STING-beta}, Snca (synuclein, alpha) [NCBI Gene 20617] {aka NACP, alpha-Syn, alphaSYN}, Pink1 (PTEN induced putative kinase 1) [NCBI Gene 68943] {aka 1190006F07Rik, BRPK, mFLJ00387}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}
- **Diseases:** dopaminergic neuronal loss (MESH:D009410), hereditary peripheral neuropathy (MESH:D009386), demyelination (MESH:D003711), AD (MESH:D000544), memory deficits (MESH:D008569), Neuroinflammation (MESH:D000090862), cortical lesion (MESH:D054220), MS (MESH:D009103), MAMs (MESH:D015433), mitochondrial distress (MESH:D012128), optic atrophy (MESH:D009896), deaths (MESH:D003643), X-linked myopathies (MESH:D020914), ALS (MESH:D000690), mitochondria (MESH:C564971), EAE (MESH:D004681), viral infection (MESH:D014777), cognitive loss (MESH:D003072), neurotoxic (MESH:D020258), weakness (MESH:D018908), DAMPs (MESH:D000081030), brain injury (MESH:D001930), Parkinson (MESH:D010302), neurological diseases (MESH:D020271), Impaired electron transportation (MESH:D028361), stroke (MESH:D020521), paralysis (MESH:D010243), Charcot-Marie-Tooth disease (MESH:D002607), PD (MESH:D010300), heart diseases (MESH:D006331), CNS disease (MESH:D002493), FTD (MESH:D003704), brain disease (MESH:D001927), muscle wasting (MESH:D009133), mitochondrial disfunction (MESH:D057215), optic atrophy-1 (MESH:D029241), metabolic syndrome (MESH:D024821), Disease (MESH:D004194), Neurodegeneration (MESH:D019636), seizure disorders (MESH:D004827), mitochondria fragmentation (MESH:D012892), hypoxia (MESH:D000860), CNS inflammation (MESH:D007249), HD (MESH:D006816), obesity (MESH:D009765), oligodendrocyte death (MESH:D056784), traumatic brain injury (MESH:D000070642), impaired motor function (MESH:D000068079)
- **Chemicals:** fatty acid (MESH:D005227), O2 (MESH:D010100), phospholipid (MESH:D010743), glucose (MESH:D005947), glutamate (MESH:D018698), K+ (MESH:D011188), iron (MESH:D007501), Unsaturated lipids (-), Sphingolipid (MESH:D013107), Ceramide (MESH:D002518), H2O2 (MESH:D006861), Cardiolipin (MESH:D002308), H2O (MESH:D014867), ATP (MESH:D000255), lactate (MESH:D019344), NO (MESH:D009569), calcium (MESH:D002118), LPS (MESH:D008070), glutathione (MESH:D005978), GTP (MESH:D006160), rotenone (MESH:D012402), Ganciclovir (MESH:D015774), lipid (MESH:D008055), ROS (MESH:D017382),  (MESH:D018836),  (MESH:D016207)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** C3 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_1098)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC8007920/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC8007920/full.md

## References

183 references — full list in the complete paper: https://tomesphere.com/paper/PMC8007920/full.md

---
Source: https://tomesphere.com/paper/PMC8007920